1. Home
  2. Analysis
  3. Lipitor
  4. Nourianz

Lipitor and Nourianz drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Nourianz (istradefylline). Common drug interactions include asthenia among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Nourianz. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

What is Nourianz?

Nourianz has active ingredients of istradefylline. eHealthMe is studying from 5,260 Nourianz users. Check the latest studies of Nourianz.

On Jul, 18, 2026

67 people who take Lipitor and Nourianz together, and have interactions are studied.

Lipitor and Nourianz drug interactions.

What are the common drug interactions of Lipitor and Nourianz, by gender? *:

female:

  1. Asthenia (weakness)
  2. Constipation
  3. Hallucination (an experience involving the perception of something not present)
  4. Death
  5. Dysphagia (a condition in which swallowing is difficult or painful)

male:

  1. Cough
  2. Dizziness
  3. General physical health deterioration (weak health status)
  4. Infection
  5. Oedema peripheral (superficial swelling)
  6. Oropharyngeal pain
  7. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  8. Hallucination (an experience involving the perception of something not present)
  9. Hallucination, visual (seeing things that aren't there)
  10. Chest pain

What are the common drug interactions of Lipitor and Nourianz, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Hallucination (an experience involving the perception of something not present)
  2. Asthenia (weakness)
  3. Cough
  4. Dizziness
  5. Chest pain
  6. Death
  7. General physical health deterioration (weak health status)
  8. Oedema peripheral (superficial swelling)
  9. Oropharyngeal pain

What are the existing conditions these people have? *

  1. Parkinson's Disease: 62 people, 92.54%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Nourianz?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lipitor and Nourianz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nourianz:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nourianz and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium and istradefylline (the active ingredients of Lipitor and Nourianz, respectively), and Lipitor and Nourianz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.